Cornea/External Disease News

Niger became the first African country to eliminate the parasitic infection onchocerciasis — also known as river blindness — and the fifth worldwide, according to WHO.

KOLOA, Hawaii — Aggressive treatment before ocular surgery helps avoid postoperative issues with visual quality in patients with dry eye disease, according to a speaker at Hawaiian Eye 2025.

KOLOA, Hawaii — Building a dry eye clinic presents a practice with new opportunities for growth, according to a speaker at Hawaiian Eye 2025.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Greg Kunst, CEO of Aurion Biotech, discusses positive phase 1/2 data for the company’s cell therapy for corneal endothelial disease.

Despite a worldwide need for more corneal transplant tissue, few options exist beyond human donors.

The Prosthetic Replacement of Ocular Surface Ecosystem was well-tolerated and appeared efficacious as a delivery system for preservative-free cyclosporine 0.05% in the treatment of dry eye disease, according to results of a pilot study.

The FDA cleared the Epithelial Thickness Module for the Anterion cornea app from Heidelberg Engineering, according to a press release.

Cold instillation of a cyclosporine A solution reduced instillation discomfort among patients with dry eye disease, with results lasting up to 9 minutes, according to research published in Optometry and Vision Science.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Sheri Rowen, MD, of NVISION Eye Centers, discusses the link between dry eye disease and menopause.